Clinical significance of soluble TNF receptor in Japanese patients with non-alcoholic steatohepatitis

Alcoholism: Clinical and Experimental Research

Volumn 29, Issue 12 SUPPL., 2005, Pages

  Tokushige, Katsutoshi ^a   Hashimoto, Etsuko ^a   Tsuchiya, Noriko ^a   Kaneda, Hiroyuki ^a   Taniai, Makiko ^a   Shiratori, Keiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

NASH; Soluble TNF Receptor

Indexed keywords

CYTOKINE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR 1; TUMOR NECROSIS FACTOR ALPHA RECEPTOR 2; UNCLASSIFIED DRUG;

ADULT; AGED; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS; HUMAN; HUMAN TISSUE; LIPID LIVER LEVEL; LIPID STORAGE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHILD; DIABETES MELLITUS; FATTY LIVER; FEMALE; HUMANS; JAPAN; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PLATELET COUNT; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II;

EID: 30144440529     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.alc.0000191810.46000.37     Document Type: Conference Paper

References (26)

1. Bemelmans MHA, Gouma DJ, Buurman WA (1994) Tissue distribution and clearance of soluble murine TNF receptors in mice. Cytokine 6:608-615.
2. Beutler B, Van Huffel C (1994) Unravelling function in the TNF ligand and receptor families. Science 264:667-668.
3. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 23:57-63.
4. Brunt EM, Janney CG, Di Biscrglie AM, Neuschwander-Tetri BA, Bacon BR (1999) Non-alcoholic steatohepatitis: a proposal for grading and staining the histological lesions. Am J Gastroenterol 94:2467-2474.
5. Brunt EM (2001) Non-alcoholic steatohepatitis: definition and pathology. Semin Liver Dis 21:3-16.
6. Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C, Karim R, Lin R, Samarasinghe D, Liddle C, Weltman M, George J (2002) NASH and insulin resistance; insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 35:373-379.
7. Crespo J, Cayon A, Fernandez-Gil P, Hernandez-Guerra M, Mayorga M, Domiguez-Diez A, Fernandez-Escalante JC, Pons-Romero F (2001) Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in non-alcoholic steatohepatitis patients. Hepatology 34:1158-1163.
8. Diez-Ruiz A, Tilz G, Gutierrez-Gea F, Gil-Extremera B, Murr C, Washter H, Fuchs D (1995) Neopterin and soluble tumor necrosis receptor type-I in alcohol-induced cirrhosis. Hepatology 21:976-978.
9. Hotamisligil GS, Perraldi P, Budavari A, Ellis R, White MF, Spiegelman BM (1996) IRS-1 mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α and obesity-induced insulin resistance. Science 271:665-668.
10. Kern WV, Engle A, Schieffer S, Prummer O, Kern P (1993) Circulating tumor necrosis (TNF) alpha, soluble TNF receptors and interleukin-6 in human subacute endocarditis. Infect Immun 61:5413-5416.
11. Kugelmans M, Hill DB, Vivian B, Marsano L, McClain CJ (2003) Cytokine and NASH: a pilot study of the effects of lifestyle modification and vitamin E. Hepatology 38:413-419.
12. Latini R, Bianchi M, Correale E, Dinarello CA, Fantuzzi G, Fresco C, Maggioni AP, Mengozzi M, Romano S, Sharpiro L (1994) Cytokines in acute myocardial infarction: Selective increase in circulating tumor necrosis, its soluble receptor and interleukin-1 receptor antagonist. J Cardiovasc Pharmacol 23:1-6.
13. Mofrad P, Contos M, Haque M, Sargeant C, Fisher RA, Luketic VA, Sterling RK, Shiffman ML, Stravitz RT, Sanyal AJ (2003) Clinical and histologic spectrum of non-alcoholic fatty liver disease associated with normal ALT values. Hepatology 37:1286-1292.
14. Mwatha JK, Kimani G, Kamau T, Mbugua GG, Ouma JH, Mumo J, Fulford AJ, Jones FM, Butteruorth AE (1998) High levels of TNF, soluble TNF receptors, soluble ICAM-1 and IFN-γ, but low levels of IL-5, are associated with hepatosplenic disease in human Schistosomiasis mansoni. J Immunol 160:1992-1999.
15. Neuschwander-Tetri BA, Caldwell SH (2003) Non-alcoholic steatohepatitis; summary of an AASLD single topic conference. Hepatology 37:1202-1219.
16. Olsson I (1993) The cytokine network. J Int Med 233:103-105.
17. Shapiro L, Clark BD, Orencole SF, Poutsiaka DD, Granowitz EV, Dinarello CA (1993) Detection of tumor necrosis factor soluble receptor p55 in blood samples from healthy and endotoxemic human. J Infect Dis 167:1344-1350.
18. Shimada M, Hashimoto E, Kanada H, Noguchi S, Hayashi N (2002) Non-alcoholic steatohepatitis: risk factors for liver fibrosis. Hepatol Res 24:429-438.
19. Starkel P, Sempoux C, Leclercq I, Herin M, Deby C, Desager JP, Horsmans Y (2003) Oxidative stress, KLF6 and transforming growth factor-beta up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from umcomplicated steatosis in rats. J Hepatol 39:538-546.
20. Teli MR, James OFW, Burt AD, Bennet MK, Day CP (1995) The natural history of non-alcoholic fatty liver: follow-up study. Hepatology 22:1714-1719.
21. Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW (1994) Interleukin-6 (IL-6) as an anti-inflammatory cytokine. Induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 83:113-118.
22. Tokushige K, Yamaguchi N, Ikeda I, Hashimoto E, Yamauchi K, Hayashi N (2000a) Significance of soluble TNF receptor-I in acute-type fulminant hepatitis. Am J Gastroenterol 95:2040-2046.
23. Tokushige K, Yamauchi K, Komatsu K, Takasaki K, Hayashi N (2000b) Predominant T helper 1 cells in patients with idiopathic portal hypertension. J Gastroenterol Hepatol 15:1312-1317.
24. Valenti L, Ludovica A, Dongiovanni P, Santorelli G, Branchi A, Taioli E, Fiorelli G, Fargion S (2002) Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in non-alcoholic fatty liver disease. Gastroenterology 122:274-280.
25. van der Poll T, Jansen J, Van Leene D, von der Mohlen M, Levi M, ten Cate H, Gallati H, ten Cate JW, van Deventer SJ (1993) Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia. J Infect Dis 168:955-960.
26. Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ, Crose RH, Cummins AG (2001) The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumor necrosis factor alpha in pathogenesis of non-alcoholic steatohepatitis. Gut 48:148-149.